News & notes.Correction, vol. 8, no. 1. In the article "Antimicrobial antimicrobial /an·ti·mi·cro·bi·al/ (-mi-kro´be-al) 1. killing microorganisms or suppressing their multiplication or growth. 2. an agent with such effects. Sensitivity in Enterobacteria en·ter·o·bac·te·ri·um n. pl. en·ter·o·bac·te·ri·a Any of various gram-negative rod-shaped bacteria of the family Enterobacteriaceae that includes some pathogens of plants and animals, such as the colon bacillus and salmonella. from AIDS Patients, Zambia," by James Mwansa et al., errors were made in calculations for the table on page 93. The corrected table appears below and online at http://www.cdc.gov/ncidod/eid/vol8no1/01-0018.htm. We regret any confusion these errors may have caused. Correction, Vol. 8, No. 4 In "Antimicrobial Use and Antimicrobial Resistance: A Population Perspective," by M. Lipsitch and M.H. Samore, the following references appeared out of order: nos. 10, 14, and 19. The corrected version appears online at http://www.cdc.gov/ncidod/EID/vol8no4/ 01-0312.htm. We regret any confusion this error may have caused. Correction, Vol. 8, No. 4 In the Letter to the Editor "O157:H7 Shiga Toxin-Producing Escherichia coli Escherichia coli (ĕsh'ərĭk`ēə kō`lī), common bacterium that normally inhabits the intestinal tracts of humans and animals, but can cause infection in other parts of the body, especially the urinary tract. Strains Associated with Sporadic sporadic /spo·rad·ic/ (spo-rad´ic) occurring singly; widely scattered; not epidemic or endemic. spo·rad·ic or spo·rad·i·cal adj. 1. Occurring at irregular intervals. 2. Cases of Diarrhea in Sao Paulo, Brazil," by Kinue Irino et al., reference no. 1 was inadvertently omitted. That reference is Griffin P, Tauxe RV. The epidemiology epidemiology, field of medicine concerned with the study of epidemics, outbreaks of disease that affect large numbers of people. Epidemiologists, using sophisticated statistical analyses, field investigations, and complex laboratory techniques, investigate the cause of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli E. coli: see Escherichia coli. E. coli in full Escherichia coli Species of bacterium that inhabits the stomach and intestines. E. coli can be transmitted by water, milk, food, or flies and other insects. , and the associated hemolytic uremic syndrome hemolytic uremic syndrome n. A syndrome in which hemolytic anemia and thrombocytopenia occur with acute renal failure, marked in children by sudden gastrointestinal bleeding, urine that contains red blood cells and is scanty in volume, and . Epidemiol Rev 1991;13:60-98. References in the text should be renumbered accordingly. The corrected version appears online at http://www.cdc/gov/ncidod/EID/ vol8no4/01-0490.htm. We regret any confusion this error may have caused. Correction, Vol. 8, No. 2 In the article "Epidemiology of Burkholderia cepacia Complex Burkholderia cepacia complex (BCC), or simply Burkholderia cepacia is a group of catalase-producing, non-lactose-fermenting Gram-negative bacteria composed of at least nine different species, including B. cepacia, B. multivorans, B. in Patients with Cystic Fibrosis cystic fibrosis (sĭs`tĭk fībrō`sĭs), inherited disorder of the exocrine glands (see gland), affecting children and young people; median survival is 25 years in females and 30 years in males. , Canada" by David P. Speert et al., an error was made in calculations for Table 2 on page 184. The corrected table appears below and online at http://www.cdc.gov/ncidod/ eid/vol8no2/01-0163.htm. In addition, the corrected percentages appear in two sentences from the results section on page 183, as follows: Most isolates (82.5%) were from genomovar III and included all strains that clustered in individual centers and appeared to be transmitted from patient to patient. Approximately 10% of infected in·fect tr.v. in·fect·ed, in·fect·ing, in·fects 1. To contaminate with a pathogenic microorganism or agent. 2. To communicate a pathogen or disease to. 3. To invade and produce infection in. patients were infected with B. multivorans (genomovar II), but there was little evidence among these isolates of genotypic genotypic emanating from or pertaining to genotype. genotypic selection selection of breeding stock on the basis of known inherited characteristics. clustering as determined by RAPD RAPD Randomly Amplified Polymorphic DNA RAPD relative afferent pupillary defect (ophthalmology; aka Marcus-Gunn Pupil) and PFGE PFGE Pulsed-Field Gel Electrophoresis . We regret any confusion this error may have caused.
Table. Antibiotic sensitivity patterns for three enterobacteria
isolated from patients with HIV-related persistent diarrhea in Zambia
Nontyphoidal Shigella
salmonellae flexneri
Antimicrobial
agent (a) No. sensitive(%) No. sensitive (%)
Tetracycline 37 (23) 2 (6)
Chlorampheni- 36 (23) 7 (23)
col
Gentamicin 119 (75) 24 (77)
Sulphamethox- 25 (16) 3 (10)
azole-trimethop-
rim
Amoxycillin 74 (47) 9 (29)
Amoxycillin- 95 (60) 27 (87)
clavulanic acid
Cephalexin 105 (66) 23 (74)
Cefuroxime 93 (59) 11 (35)
Cefotaxime 149 (94) 28 (90)
Nalidixic acid 107 (68) 31 (100)
Ciprofloxacin 157 (99) 30 (97)
Erythromycin 22 (14) 0 (0)
Azithromycin 64 (93) 9 (100)
Shigella
dysenteriae
Antimicrobial
agent (a) No. sensitive (%)
Tetracycline 3 (16)
Chlorampheni- 8 (42)
col
Gentamicin 18 (95)
Sulphamethox- 0 (0)
azole-trimethop-
rim
Amoxycillin 7 (37)
Amoxycillin- 12 (63)
clavulanic acid
Cephalexin 17 (89)
Cefuroxime 16 (84)
Cefotaxime 19 (100)
Nalidixic acid 19 (100)
Ciprofloxacin 18 (95)
Erythromycin 4 (21)
Azithromycin 19 (100)
(a) One hundred fifty-eight isolates of nontyphoidal salmonellae, 31 of
S. flexneri, and 19 of S. dysenteriae were tested against all these
antimicrobial agents, except for azithromycin, against which 69, 9, and
19 isolates were tested, respectively.
Table 2. Genomovar or species of Burkholderia cepacia complex or
phenotypically similar isolates from cystic fibrosis patients in Canada
No. of patients
infected with Percentage of
Species or genomovar species or genomovar (a) patients (%)
Genomovar I 1 0.2
Burkholderia multi- 43 9.6
vorans (genomovar II)
Genomovar III 369 82.5
Burkholderia stabilis 17 3.8
(genomovar IV)
Burkholderia vietnamien- 7 1.6
sis (genomovar V)
Burkholderia cepacia 8 1.8
complex (not genomovar
I-VII)
Burkholderiafungorum 1 0.2
Burkholderia gladioli 5 1.1
Ralstonia pickettii 5 1.1
Pandoraea spp. 5 1.1
Total 461 (a)
(a) Some patients were counted twice if two or more different strains
were recovered; therefore, the percentage of patients is based on a
denominator of 447.
Emerging Infectious Diseases An emerging infectious disease (EID) is an infectious disease whose incidence has increased in the past 20 years and threatens to increase in the near future. EIDs include diseases caused by a newly identified microorganism or newly identified strain of a known microorganism (e.g. Policy on Corrections The Emerging Infectious Diseases journal wishes error-free articles. To that end, we 1) Make corrections as quickly as we become aware of errors 2) Publish corrections online and in print. Online, we correct the error in the article it occurred with a note that the article was corrected and the date of correction. In print, we prominently publish a full correction, printing all needed information, and provide the URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. of the corrected online article for reprints. For additional information on corrections, send email to eideditoracdc.gov. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion